About the project
This project is focused on transforming respiratory care at the bedside to develop a user-friendly, palmtop spectrometer that brings rapid bedside biomarker diagnosis within easy reach for clinicians.
Acute respiratory distress syndrome (ARDS), a widespread respiratory condition affecting all ages, causes respiratory failure due to inflamed, fluid-filled lungs hindering gas exchange. COVID-19 highlighted ARDS globally, leading to hospitalizations and deaths. No specific therapy exists, and surfactant loss worsens outcomes, with 30-50% mortality.
Oxygen therapy is crucial but excessive administration can damage tissues. Our study proposes on-chip spectroscopy for rapid in-vivo surfactant analysis, aiding precise treatments and prevention across all ages.
Building on our success in mid-infrared spectroscopy and machine learning, our team is creating a practical point-of-care device. Utilizing disposable enhanced spectroscopic chips, this project aims to analyse in-vivo surfactant metabolism swiftly. By doing so, clinicians can make informed decisions, stratify patients, and prescribe targeted therapies promptly.
Join us in shaping the future of respiratory diagnostics and making a real impact in healthcare.
The Optoelectronics Research Centre is committed to promoting equality, diversity, and inclusivity, as demonstrated by the school’s Athena Swan award. We welcome all applicants regardless of their gender, ethnicity, disability, sexual orientation or age. We take personal circumstances into account, and will give full consideration to applicants seeking to study part time. The campus has onsite childcare facilities.
